While the melanoma clinical trial at Hollings is no longer enrolling patients, a clinical trial using the same approach in non-small-cell lung cancer is still open. Moderna, which helped develop one of the two primary COVID-19 vaccines, has expanded mRNA use not only to cancer but also to flu, respiratory syncytial virus and norovirus, among others just being tested in …
Read More »